Not Signed In - Main Topic Area
All Topic Areas
1 - 10 of 89 more >>
Clinical Trials
1 - 5 of 11 more >>
- Rasburicase in Treating or Preventing High Levels of Uric Acid in the Blood and Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumors
ClinicalTrials.gov Identifier: NCT00086918 - Active, not recruiting
Cancer; hyperuricemia; Tumor Lysis Syndrome
- Rasburicase in Tumor Lysis Syndrome
ClinicalTrials.gov Identifier: NCT00302653 - Active, not recruiting
Hyperuricemia
- Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
ClinicalTrials.gov Identifier: NCT00186940 - Recruiting
Leukemia; Lymphoma
- Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
ClinicalTrials.gov Identifier: NCT00057811 - Recruiting
acute leukemia; childhood large cell lymphoma; childhood small noncleaved cell lymphoma; Drug Toxicity
- Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
ClinicalTrials.gov Identifier: NCT00230217 - Active, not recruiting
Tumors; Hyperuricemia; Tumor Lysis Syndrome
email this page
print this page
bookmark this page
feedback on this page
